Programming of growth hormone secretion and bone mineral density in elderly men: A hypothesis

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 135-139

  Fall, Caroline ^a   Hindmarsh, Peter ^b   Dennison, Elaine ^a   Kellingray, Samantha ^a   Barker, David ^a   Cooper, Cyrus ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BONE DENSITY; BONE MINERALIZATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENVIRONMENTAL FACTOR; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AGED; AGING; BIOLOGICAL MARKERS; BIRTH WEIGHT; BODY WEIGHT; BONE DENSITY; CARRIER PROTEINS; CIRCADIAN RHYTHM; ENVIRONMENT; FEMUR; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SPINE; WEIGHT GAIN;

EID: 0031794842     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.1.135     Document Type: Article

References (49)

1. Cummings SR, Nevitt MC, Browner WS, et al. 1995 Risk factors for hip fracture in white women. N Engl J Med. 332:767-773.
2. Cooper C, Cawley MID, Bhalla A, et al. 1995 Childhood growth, physical activity and peak bone mass in women. J Bone Miner Res. 10:940-947.
3. Cooper C, Fall C, Egger P, Hobbs R, Eastell R, Barker D. 1997 Growth in infancy and bone mass in later life. Ann Rheum Dis. 56:17-21.
4. Gluckman P. 1989 Fetal growth: an endocrine perspective. Acta Paediatr Scand. 349(Suppl):21-25.
5. Van de Weghe M. 1993 Long-term consequences of growth hormone deficiency acquired in childhood. Acta Endocrinol (Copenh). 128(Suppl 2):6-8.
6. Wüster C. 1993 Growth hormone and bone metabolism. Acta Endocrinol (Copenh). 128(Suppl 2):14-18.
7. Hyer SL, Rodin D, Tobias J, Leiper A, Nussey S. 1992 Growth hormone deficiency during puberty reduces adult BMD. Arch Dis Child. 67:1472-1474.
8. De Boer H, Blok G, Van Lingen A, Teule G, Lips P, Van der Veen E. 1994 Consequences of childhood onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 9:1319-26.
9. Kaufman J-M, Taelman P, Vermeulen A, Van de Weghe M. 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 74:118-123.
10. Diamond T, Nery L, Posen L. 1989 Spinal and peripheral bone densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med. 111:567-573.
11. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR. 1993 Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab. 76:1452-1457.
12. O'Sullivan A, Kelly J, Hoffman D, Freund J, Ho K. 1994 Body composition and expenditure in acromegaly. J Clin Endocrinol Metab. 78:381-386.
13. Kolzmann H, Bernecker P, Hubsch P, et al. 1993 BMD and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res. 8:459-465.
14. Hales CN, Barker DJP, Clark PMS, et al. 1991 Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J. 303:1019-1022.
15. Egger P, Duggleby S, Hobbs R, Fall C, Cooper C. 1996 Cigarette smoking and bone mineral density in the elderly. J Epidemiol Comm Health. 50:47-50.
16. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower post-glucose nadir GH concentrations in men and women. J Clin Endocrinol Metab. 78:1312-1319.
17. Carlsson LMS, Rowland AM, Clark RG, Gesundheit N, Wong WLT. 1994 Ligand-mediated immunofunctional assay (LIFA) for quantification of growth hormone binding protein in human blood. J Clin Endocrinol Metab. 73:1216-1223.
18. Anderson FH, Francis RM, Hindmarsh P, Fall C, Cooper C. 1996 Serum estradiol in osteoporotic and normal men is related to bone mineral density. In: Papapoulos SE, Lips P, Pols HAP, Johnston CC, Delmas PJ, eds. Osteoporosis 1996. Amsterdam: Elsevier; 377-381.
19. Carter DR, Bouxsein ML, Marcus P. 1992 New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137-145.
20. Kellgren JH, Lawrence JS, eds. 1963 Epidemiology of chronic rheumatism: atlas of standard radiographs. Oxford: Blackwell.
21. Wright NM, Renault J, Wili S, et al. 1995 Greater secretion of growth hormone in black than in white men: possible factor in greater bone density-a Clinical Research Center Study. J Clin Endocrinol Metab. 80:2291-2297.
22. Johansson A, Lindh, E, Ljunghall S. 1993 IGFs: function and clinical importance: growth hormone, insulin-like growth factor I, and bone: a clinical review. J Intern Med. 234:553-560.
23. Rosen CJ, Donahue LR, Hunter SJ. 1994 Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med. 206:83-102.
24. Van de Weghe M, Taelman P, Kaufman JM. 1993 Short and long term effects of growth hormone therapy on bone turnover and BMC in adult growth hormone deficient males. Clin Endocrinol (Oxf). 39:409-415.
25. Orme SM, Sebastian JP, Oldroyd B, et al. 1992 Comparison of measured body composition in a trial of low dose growth hormone replacement treatment. Clin Endocrinol (Oxf). 37:453-459.
26. Holmes S, Economon G, Whitehouse R, Adams J, Shalet S. 1994 Reduced BMD in patients with adult onset growth health deficiency. J Clin Endocrinol Metab. 78:669-674.
27. Degerblad M, Elgindy N, Hall K. Sjöberg HE, Thorén M. 1992 Potent effect of recombinant growth hormone on BMD and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387-393.
28. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG. 1995 The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol (Oxf). 42:249-254.
29. Rudman D, Feller AG, Nagrog HS, et al. 1990 Effect of human growth hormone in men over age 60. N Engl J Med. 323:52-54.
30. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effect of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79:470-479.
31. Holloway L, Kohlmeier L, Kent K, Marcus P. 1997 Skeletal effects of cyclical recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J Clin Endocrinol Metab 82:1111-1117.
32. Cronin MJ, Thorner MO. 1989 Basic studies with GH releasing factor. In: De Groot LJ, ed. Endocrinology. Philadelphia: Saunders; vol 1:183-191.
33. Hindmarsh PC, Stanhope R, Kendall BE, Brook CGD. 1986 Tall stature: a clinical, endocrinological and radiological study. Clin Endocrinol (Oxf). 25:223-231.
34. Hindmarsh PC, Smith PJ, Brook CGD, Matthews DR. 1987 The relationship between height velocity and GH secretion in short prepubertal children. Clin Endocrinol (Oxf). 27:581-591.
35. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD. 1987 Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab. 64:596-601.
36. Albertsson-Wikland K, Rosberg S. 1988 Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab. 67:493-500.
37. Ho KK, Weissberger AJ. 1994 Characterisation of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin Endocrinol (Oxf). 41:75-83.
38. Kotzmann H, Bernecker P, Hubsch P, et al. 1993 Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res. 8:459-465.
39. Ho JP, Fig LM, Barkan AL, Shapiro B. 1992 Bone mineral density of the axial skeleton in acromegaly. J Nucl Med. 33:1608-1612.
40. Kayath MJ, Vieira JGH. 1997 Osteopenia occurs in a minority of patients with acromegaly and is perdominant in the spine. Osteopor Int. 7:226-230.
41. Jansson J-O, Ekberg S, Isaksson O, Mode A, Gustafsson J-A. 1985 Imprinting of growth hormone secretion, body growth and hepatic steroid metabolism by neonatal testosterone. Endocrinology. 117:1881-1889.
42. Harel Z, Tannenbaum GS. 1995 Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat. Pediatr Res. 38:747-753.
43. de Zegher F, Kimpen J, Raus J, Vanderschuren-Lodeweyckx M. 1990 Hypersomatotropism in the dysmature infant at term and preterm birth. Biol Neonate. 58:188-191.
44. Leger J, Noel M, Limal JM, Czernichow P. 1996 Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) 1, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Pediatr Res. 40:101-107.
45. Hirano T, Chin I, Miyamoto Y, Jogamoto M, Ishikawa E. 1989 Cross-sectional assessments of growth hormone concentrations in normal neonates in the first week of life. Acta Paediatr Scand. 356:126.
46. Ackland FM, Stanhope R, Eyre C, Hamill G, Jones J, Preece MA. 1988 Physiological growth hormone secretion in children with short stature and intra-uterine growth retardation. Horm Res. 30:241-245.
47. Albertsson-Wikland K. 1989 Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Acta Paediatr Scand. 349(Suppl):35-41.
48. Holmes GE, Miller HC, Hassanein K. Lansky SB, Goggin JE. 1977 Postnatal somatic growth in infants with atypical fetal growth patterns. Am J Dis Child. 131:1078-1083.
49. Villar J, Smeriglio V, Martorell R, Brown CH, Klein RE. 1984 Heterogeneous growth and mental development in intrauterine growth retarded infants during the first three years of life. Pediatrics. 74:783-791.